This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sk Chemicals Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Yong-kyu Kwak in Pharmaceutical Sciences
Introduction
Yong-kyu Kwak, based in Seoul, South Korea, is an accomplished inventor known for his significant contributions to pharmaceutical sciences. With a focus on innovative drug delivery systems, he has developed a unique formulation that enhances the effectiveness of therapies for sex hormone-dependent diseases.
Latest Patents
Yong-kyu Kwak holds a patent for a pharmaceutical composition containing leuprolide, which is designed to provide both immediate and sustained release properties. This invention is specifically beneficial as it allows for the prompt exposure to an effective amount of the drug in the early stages of treatment while maintaining its effects over a prolonged period, extending up to four weeks or longer. The formulation consists of leuprolide as an immediate release preparation, making up 0.001 wt % to 25 wt % of the total active ingredients, while microspheres containing leuprolide for sustained release account for 75 wt % to 99.999 wt %.
Career Highlights
Yong-kyu Kwak is associated with SK Chemicals Co., Ltd., a prominent company in the chemical and pharmaceutical domain. His innovative approach has not only led to advancements in drug formulations but also reinforced the company’s reputation for cutting-edge research and development in therapeutic solutions.
Collaborations
Throughout his career, Yong-kyu Kwak has worked alongside esteemed colleagues, including Hong Kee Kim and Kyu Ho Lee. These collaborations have facilitated the exchange of ideas and expertise, contributing to the success of his research and patent applications.
Conclusion
Yong-kyu Kwak's contributions to pharmaceutical sciences, particularly through his patented composition that combines immediate and sustained drug release properties, represent a significant advancement in medical treatments. His work continues to pave the way for innovative solutions in addressing complex health challenges associated with hormone-dependent diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile